Evaluation of serodiagnosis (beta-D-glucan) screening for invasive fungal infection on intracavitary surgical site infection(SSI)

Evaluation of serodiagnosis (beta-D-glucan) screening for invasive fungal infection on intracavitary surgical site infection(SSI) - Evaluation of beta-D-glucan screening for invasive fungal infection on intracavitary SSI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003133

Enrollment

100

Registered

2010-02-03

Start date

2010-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal surgical patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who develop perioperative intracavitary surgical site infection after gastrointestinal surgery

Exclusion criteria

Exclusion criteria: Pregnant or patients might be pregnant ,and lactating patients Patients treated with antifungal at study registration Patients diagnosed as fungal infections at study registration Patients not expected to survive during study due to very serious underlying disease or infection Patients considered as inappropriate for study by investigators

Design outcomes

Primary

Measure	Time frame
Positive ratio of beta-D-glucan at onset of intracavitary surgical site infections Fungal culture tests	—

Secondary

Measure	Time frame
Incidence of fungal infections at each surgical site Clinical risk factors for fungal infections Usefulness of antifungal treatment	—

Countries

Japan

Contacts

Public ContactKei Nakagawa

Tohoku University Graduate School of Medicine Division of Integrated Surgery and Oncology

kein_h11@surg1.med.tohoku.ac.jp022-717-7205

Outcome results